Given the reports about the high-risk practices taking place in London (and likely other cities in high-income countries), it is likely that cases of sexually transmitted HCV are also occurring in some HIV-negative MSM. To investigate this possibility, researchers in London reviewed health-related information collected from HIV-negative patients who sought care at selected clinics in that city.
01 October 2014 | CATIE
The Kirby Institute’s Annual Surveillance Report suggests a number of STIs are continuing to increase, with syphilis and gonorrhoea leading the charge. Hepatitis C infections are also a growing health issue with more people now dying from viral hepatitis infection than from HIV when it was in its peak in the 80s and 90s.
22 September 2014 | Gay News Network
While screening the blood samples of patients for HCV antibodies can be useful, a new study suggests that in some cases such antibodies may not appear for several months after HCV infection has occurred. In such cases, acute HCV infection might be missed if antibody tests alone are used for screening - RNA testing should be used to screen HCV infection.
17 September 2014 | CATIE
HIV-negative men who have sex with men (MSM) are apparently at risk for sexual acquisition of hepatitis C virus (HCV), the National AIDS Treatment Advocacy Project reports. Their risk factors are likely similar to those of HIV-positive men. Researchers at Chelsea and Westminster Hospital in London conducted a retrospective study of the clinic’s patients in which they identified 44 acute cases of hep C among HIV-negative MSM between January 2010 and December 2013.
09 September 2014 | Aidsmeds.com
"In places like Bali, Thailand, Vietnam and the Philippines, hepatitis C can be nine or 10 times more prevalent than at home, and this coupled with generally lower standards of equipment sterilisation in the average tattoo parlour or where you get pedicures can greatly increase the risk of infection," Tyrell says.
01 September 2014 | Courier Mail
Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health.
05 August 2014 | Eurekalert Medicine & Health
The resolution urges member states “to develop multisectoral national strategies for preventing, diagnosing, and treating viral hepatitis.” The resolution also asks states to consider using the flexibilities endorsed in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to promote access to specific pharmaceutical products.
23 May 2014 | Intellectual Property Watch
Today, four years after introducing its first viral hepatitis resolution, the World Health Assembly (WHA)—the decision-making body of the World Health Organization (WHO)—passed the Hepatitis Resolution, which commits the WHO and United Nations (UN) member states to urgent action to address the global hepatitis pandemic, including that of hepatitis C virus (HCV).
23 May 2014 | Treatment Action Group
In 2010, the 63rd World Health assembly (WHA) adopted the first resolution on viral hepatitis; a new resolution will be presented at this assembly. We, people living with HCV, HIV/AIDS, people who use drugs, and our advocates, urge United Nations (UN) Member States to act with urgency to end the hepatitis C epidemic; it is possible!
21 May 2014 | Treatment Action Group
The nation's oversized prison population provides an opportunity to battle the US hepatitis C epidemic because inmates have a high prevalence of infection and are readily reachable for testing and treatment, argue authors of a new article in the New England Journal of Medicine. One in six inmates is infected and one in three infected Americans ends up locked up for at least a little time in their lives.
15 May 2014 | Eurekalert Inf Dis